Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2002-8-19
pubmed:abstractText
Activation of the neuronal sigma(1) (sigma(1)) receptor potentiates calcium mobilization, leading to effective modulation of postsynaptic responses to neurotransmitters. At the behavioral level, sigma(1) agonists modulate learning, response to stress and depression. In particular, the selective sigma(1) agonist igmesine reduced immobility in the forced swimming test.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents, Tricyclic, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Agonists, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels, L-Type, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channels, N-Type, http://linkedlifedata.com/resource/pubmed/chemical/Chelating Agents, http://linkedlifedata.com/resource/pubmed/chemical/Cinnamates, http://linkedlifedata.com/resource/pubmed/chemical/Cyclopropanes, http://linkedlifedata.com/resource/pubmed/chemical/Desipramine, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, sigma, http://linkedlifedata.com/resource/pubmed/chemical/Ryanodine Receptor Calcium Release..., http://linkedlifedata.com/resource/pubmed/chemical/igmesine, http://linkedlifedata.com/resource/pubmed/chemical/sigma-1 receptor
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0033-3158
pubmed:author
pubmed:issnType
Print
pubmed:volume
163
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
26-35
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12185397-Adrenalectomy, pubmed-meshheading:12185397-Animals, pubmed-meshheading:12185397-Antidepressive Agents, pubmed-meshheading:12185397-Antidepressive Agents, Tricyclic, pubmed-meshheading:12185397-Behavior, Animal, pubmed-meshheading:12185397-Calcium, pubmed-meshheading:12185397-Calcium Channel Agonists, pubmed-meshheading:12185397-Calcium Channel Blockers, pubmed-meshheading:12185397-Calcium Channels, L-Type, pubmed-meshheading:12185397-Calcium Channels, N-Type, pubmed-meshheading:12185397-Chelating Agents, pubmed-meshheading:12185397-Cinnamates, pubmed-meshheading:12185397-Cyclopropanes, pubmed-meshheading:12185397-Depression, pubmed-meshheading:12185397-Desipramine, pubmed-meshheading:12185397-Injections, Intraventricular, pubmed-meshheading:12185397-Male, pubmed-meshheading:12185397-Mice, pubmed-meshheading:12185397-Orchiectomy, pubmed-meshheading:12185397-Receptors, sigma, pubmed-meshheading:12185397-Ryanodine Receptor Calcium Release Channel, pubmed-meshheading:12185397-Swimming
pubmed:year
2002
pubmed:articleTitle
The antidepressant-like effect induced by the sigma(1) (sigma(1)) receptor agonist igmesine involves modulation of intracellular calcium mobilization.
pubmed:affiliation
Département de Biochimie/Enzymologie, Pfizer GRD-Fresnes, 3/9, rue de la Loge, BP 100, 94265 Fresnes Cedex, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't